Pharma Journalist -

Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, announced the closing of a $37 million Series A financing led by Kineticos Ventures.…
Read More...

Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cosentyx (secukinumab), used alone…
Read More...

PTC Therapeutics, Inc. announced that Upstaza (eladocagene exuparvovec; PTC-AADC) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the…
Read More...

Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s…
Read More...

Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and…
Read More...

AbbVie announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor…
Read More...

Eli Lilly and Company and Incyte announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT …
Read More...

The mega PURIFY’22 held on 7th April, 2022 at ITC Kohenur, Hyderabad can be summed up as 22 globally acclaimed speakers, addressing 223 delegates who converged from 26 cities across 80…
Read More...

Sinclair Pharma, a global pharmaceutical brand providing aesthetic dermatology and collagen solutions is collaborating exclusively with Vanguard Aesthetics to bring the Silhouette Soft…
Read More...

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that a new…
Read More...